** Shares of Chinese internet healthcare provider JD Health
International Inc 6618.HK fall as much as 7.8% to HK$109.20,
on course for worst session since March 8
** Stock is second-biggest percentage decliner in Hang Seng
Tech Index .HSTECH and among the 30-most actively traded by
turnover
** Brokerage Daiwa Capital Markets cuts JD Health's TP to
HK$130.50 from HK$148.20 on lower avg valuation than peers in
past few months, regulatory uncertainties and inflation fears
** However, Daiwa upgrades stock to "outperform" from "hold"
on "more reasonable" valuation after >20% drop in the past 4
months, its robust growth momentum and strong growth outlook
** The Hang Seng Tech Index .HSTECH falls 2.2% and the
healthcare index .HSCIH drops 1.4%
** The Hang Seng China enterprises index .HSCE eases 0.8%
and the benchmark index .HSI slips 0.4%
** As of last close, the stock of the Beijing-based company
fell 21.1% this year
(Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)